We assessed the proliferative potential of CD4+ and CD8+ T cells derived from AML or WT mice by culturing whole splenocytes on anti-CD3 coated plates for 3 days, thus relying on naturally occurring antigen-presenting cells for co-stimulation. The gene discussed is CD8A; the disease is acute myeloid leukemia.